Metabolic engineering of Escherichia coli for production of salvianic acid A via an artificial biosynthetic pathway

Metabolic Engineering

Volumn 19, Issue , 2013, Pages 79-87

  Yao, Yuan Feng ^a   Wang, Chang Song ^a   Qiao, Jianjun ^a   Zhao, Guang Rong ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

D lactate dehydrogenase; Escherichia coli; HpaBC; Metabolic engineering; Salvianic acid A

Indexed keywords

ANTI-OXIDANT ACTIVITIES; BIOSYNTHETIC PATHWAY; CARDIO-VASCULAR DISEASE; D-LACTATE DEHYDROGENASE; ENGINEERING APPROACHES; HPABC; SALVIANIC ACID A; THERAPEUTIC POTENTIALS;

AMINO ACIDS; BIOSYNTHESIS; ENCODING (SYMBOLS); GLUCOSE; METABOLIC ENGINEERING; PLANTS (BOTANY);

ESCHERICHIA COLI;

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; DEXTRO LACTATE DEHYDROGENASE; ESCHERICHIA COLI PROTEIN; GLUCOSE; HPABC PROTEIN; OXYGENASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOSYNTHESIS; DNA SEQUENCE; ESCHERICHIA COLI; FED BATCH FERMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOLOGOUS RECOMBINATION; LACTOBACILLUS PENTOSUS; METABOLIC ENGINEERING; MOLECULAR WEIGHT; NONHUMAN; OPTICAL DENSITY; PLANT ROOT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRODUCTIVITY; PROTEIN EXPRESSION;

D-LACTATE DEHYDROGENASE; ESCHERICHIA COLI; HPABC; METABOLIC ENGINEERING; SALVIANIC ACID A;

CAFFEIC ACIDS; ESCHERICHIA COLI; GLUCOSE; LACTATE DEHYDROGENASES; LACTATES; LACTOBACILLUS; METABOLIC ENGINEERING; MIXED FUNCTION OXYGENASES; PLANT ROOTS; SALVIA MILTIORRHIZA;

EID: 84880677911     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2013.06.001     Document Type: Article

References (53)

1. Ajikumar P.K., Xiao W.H., Tyo K.E., et al. Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 2010, 330:70-74.
2. Atsumi S., Higashide W., Liao J.C. Direct photosynthetic recycling of carbon dioxide to isobutyraldehyde. Nat. Biotechnol. 2009, 27:1177-1180.
3. Bongaerts J., Kramer M., Muller U., et al. Metabolic engineering for microbial production of aromatic amino acids and derived compounds. Metab. Eng. 2001, 3:289-300.
4. Bubl E.C., Butts J.S. A method of synthesis of phenyllactic acid and substituted phenyllactic acids. J. Am. Chem. Soc. 1951, 73. 4972-4972.
5. Cadieux P.A., Burton J., Devillard E., et al. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J. Physiol. Pharmacol. 2009, 60(6):13-18.
6. Chavez-Bejar M.I., Lara A.R., Lopez H., et al. Metabolic engineering of Escherichia coli for L-tyrosine production by expression of genes coding for the chorismate mutase domain of the native chorismate mutase-prephenate dehydratase and a cyclohexadienyl dehydrogenase from Zymomonas mobilis. Appl. Environ. Microbiol. 2008, 74:3284-3290.
7. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U S A 2000, 97:6640-6645.
8. Dong C., Wang Y., Zhu Y.Z. Asymmetric synthesis and biological evaluation of Danshensu derivatives as anti-myocardial ischemia drug candidates. Bioorg. Med. Chem. 2009, 17:3499-3507.
9. Doy C.H. Alkaline conversion of 4-hydroxyphenylpyruvic acid to 4-hydroxybenzaldehyde. Nature 1960, 186:529-531.
10. Gosset G. Production of aromatic compounds in bacteria. Curr. Opin. Biotechnol. 2009, 20:651-658.
11. Hernandez-Montalvo V., Martinez A., Hernandez-Chavez G., et al. Expression of galP and glk in a Escherichia coli PTS mutant restores glucose transport and increases glycolytic flux to fermentation products. Biotechnol. Bioeng. 2003, 83:687-694.
12. Huang Z.S., Zeng C.L., Zhu L.J., et al. Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase. J. Thromb. Haemost. 2010, 8:1383-1393.
13. Ikeda M. Towards bacterial strains overproducing L-tryptophan and other aromatics by metabolic engineering. Appl. Microbiol. Biotechnol. 2006, 69:615-626.
14. Ishikura Y., Tsuzuki S., Takahashi O., et al. Recognition site for the side chain of 2-ketoacid substrate in d-lactate dehydrogenase. J. Biochem. 2005, 138:741-749.
15. Ito H., Sato K., Enei H., et al. Improvement in microbial production of L-tyrosine by gene dosage effect of aroL gene encoding shikimate kinase. Agric. Biol. Chem. 1990, 54:823-824.
16. Janiak V., Petersen M., Zentgraf M., et al. Structure and substrate docking of a hydroxy(phenyl)pyruvate reductase from the higher plant Coleus blumei Benth. Acta Crystallogr. D Biol. Crystallogr. 2010, 66:593-603.
17. Jia Y., Dong X., Zhou P., et al. The synthesis and biological evaluation of novel Danshensu-cysteine analog conjugates as cardiovascular-protective agents. Eur. J. Med. Chem. 2012, 55:176-187.
18. Juminaga D., Baidoo E.E., Redding-Johanson A.M., et al. Modular engineering of L-tyrosine production in Escherichia coli. Appl. Environ. Microbiol. 2012, 78:89-98.
19. Kai G., Xu H., Zhou C., et al. Metabolic engineering tanshinone biosynthetic pathway in Salvia miltiorrhiza hairy root cultures. Metab. Eng. 2011, 13:319-327.
20. Kang S.Y., Choi O., Lee J.K., et al. Artificial biosynthesis of phenylpropanoic acids in a tyrosine overproducing Escherichia coli strain. Microb. Cell Fact. 2012, 11:153.
21. Kikuchi Y., Tsujimoto K., Kurahashi O. Mutational analysis of the feedback sites of phenylalanine-sensitive 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase of Escherichia coli. Appl. Environ. Microbiol. 1997, 63:761-762.
22. Lam F.F., Yeung J.H., Chan K.M., et al. Relaxant effects of danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels. Vascul. Pharmacol. 2007, 46:271-277.
23. Liebgott P.-P., Amouric A., Comte A., et al. Hydroxytyrosol from tyrosol using hydroxyphenylacetic acid-induced bacterial cultures and evidence of the role of 4-HPA 3-hydroxylase. Res. Microbiol. 2009, 160:757-766.
24. Lin Y., Yan Y. Biosynthesis of caffeic acid in Escherichia coli using its endogenous hydroxylase complex. Microb. Cell Fact. 2012, 11:42.
25. Lutke-Eversloh T., Stephanopoulos G. Feedback inhibition of chorismate mutase/prephenate dehydrogenase (TyrA) of Escherichia coli: generation and characterization of tyrosine-insensitive mutants. Appl. Environ. Microbiol. 2005, 71:7224-7228.
26. Lutke-Eversloh T., Stephanopoulos G. Combinatorial pathway analysis for improved L-tyrosine production in Escherichia coli: identification of enzymatic bottlenecks by systematic gene overexpression. Metab. Eng. 2008, 10:69-77.
27. Muir R.M., Ibanez A.M., Uratsu S.L., et al. Mechanism of gallic acid biosynthesis in bacteria (Escherichia coli) and walnut (Juglans regia). Plant Mol. Biol. 2011, 75:555-565.
28. Munoz A.J., Hernandez-Chavez G., de Anda R., et al. Metabolic engineering of Escherichia coli for improving L-3,4-dihydroxyphenylalanine (L-DOPA) synthesis from glucose. J. Ind. Microbiol. Biotechnol. 2011, 38:1845-1852.
29. Na D., Yoo S.M., Chung H., et al. Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs. Nat. Biotechnol. 2013, 31:170-174.
30. Neidhardt F.C., Bloch P.L., Smith D.F. Culture medium for enterobacteria. J. Bacteriol. 1974, 119:736-747.
31. Oh K.S., Oh B.K., Mun J., et al. Salvianolic acid A suppress lipopolysaccharide-induced NF-kappaB signaling pathway by targeting IKKbeta. Int. Immunopharmacol. 2011, 11:1901-1906.
32. Oldiges M., Kunze M., Degenring D., et al. Stimulation, monitoring, and analysis of pathway dynamics by metabolic profiling in the aromatic amino acid pathway. Biotechnol. Prog. 2004, 20:1623-1633.
33. Patnaik R., Liao J.C. Engineering of Escherichia coli central metabolism for aromatic metabolite production with near theoretical yield. Appl. Environ. Microbiol. 1994, 60:3903-3908.
34. Patnaik R., Spitzer R.G., Liao J.C. Pathway engineering for production of aromatics in Escherichia coli: confirmation of stoichiometric analysis by independent modulation of AroG, TktA, and Pps activities. Biotechnol. Bioeng. 1995, 46:361-370.
35. Pojer F., Wemakor E., Kammerer B., et al. CloQ, a prenyltransferase involved in clorobiocin biosynthesis. Proc. Natl. Acad. Sci. U S A 2003, 100:2316-2321.
36. Polen T., Kramer M., Bongaerts J., et al. The global gene expression response of Escherichia coli to L-phenylalanine. J. Biotechnol. 2005, 115:221-237.
37. Ro D.K., Paradise E.M., Ouellet M., et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440:940-943.
38. Santos C.N., Koffas M., Stephanopoulos G. Optimization of a heterologous pathway for the production of flavonoids from glucose. Metab. Eng. 2011, 13:392-400.
39. Santos C.N., Stephanopoulos G. Melanin-based high-throughput screen for L-tyrosine production in Escherichia coli. Appl. Environ. Microbiol. 2008, 74:1190-1197.
40. Santos C.N., Xiao W., Stephanopoulos G. Rational, combinatorial, and genomic approaches for engineering L-tyrosine production in Escherichia coli. Proc. Natl. Acad. Sci. U S A 2012, 109:13538-13543.
41. Satoh Y., Tajima K., Munekata M., et al. Engineering of L-tyrosine oxidation in Escherichia coli and microbial production of hydroxytyrosol. Metab. Eng. 2012, 14:603-610.
42. Sayyed I.A., Sudalai A. Asymmetric synthesis of l-DOPA and (R)-selegiline via, OsO4-catalyzed asymmetric dihydroxylation. Tetrahedron: Asymmetry 2004, 15:3111-3116.
43. Tang M.K., Ren D.C., Zhang J.T., et al. Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 2002, 9:405-409.
44. Varma A., Boesch B.W., Palsson B.O. Biochemical production capabilities of Escherichia coli. Biotechnol. Bioeng. 1993, 42:59-73.
45. Verhoef S., Wierckx N., Westerhof R.G., et al. Bioproduction of p-hydroxystyrene from glucose by the solvent-tolerant bacterium Pseudomonas putida S12 in a two-phase water-decanol fermentation. Appl. Environ. Microbiol. 2009, 75:931-936.
46. Wang X.J., Xu J.X. Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Neurosci. Res. 2005, 51:129-138.
47. Warnecke T., Gill R.T. Organic acid toxicity, tolerance, and production in Escherichia coli biorefining applications. Microb. Cell Fact. 2005, 4:25.
48. Xue X., Li W., Li Z., et al. Enhanced 1,3-propanediol production by supply of organic acids and repeated fed-batch culture. J. Ind. Microbiol. Biotechnol. 2010, 37:681-687.
49. Xun L., Sandvik E.R. Characterization of 4-hydroxyphenylacetate 3-hydroxylase (HpaB) of Escherichia coli as a reduced flavin adenine dinucleotide-utilizing monooxygenase. Appl. Environ. Microbiol. 2000, 66:481-486.
50. Zhang H., Stephanopoulos G. Engineering E. coli for caffeic acid biosynthesis from renewable sugars. Appl. Microbiol. Biotechnol. 2013, 97:3333-3341.
51. Zhao G.R., Zhang H.M., Ye T.X., et al. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem. Toxicol. 2008, 46:73-81.
52. Zhou L., Zuo Z., Chow M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 2005, 45:1345-1359.
53. Zhu Y.Z., Huang S.H., Tan B.K., et al. Antioxidants in Chinese herbal medicines: a biochemical perspective. Nat. Prod. Rep. 2004, 21:478-489.